NASDAQ:MMSI - Merit Medical Systems Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$59.38 -0.30 (-0.50 %)
(As of 03/20/2019 12:00 PM ET)
Previous Close$59.68
Today's Range$59.38 - $59.94
52-Week Range$43.05 - $66.34
Volume2,532 shs
Average Volume479,136 shs
Market Capitalization$3.26 billion
P/E Ratio35.22
Dividend YieldN/A
Beta1.1
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions. The company also offers cardiovascular and critical care products to treat patients with life-threatening diseases, protect healthcare providers from exposure to bloodborne pathogens, and provide medical devices. In addition, it provides interventional oncology and spine products comprising delivery system, embolotherapy, spine ablation, and vertebral compression fracture products to treat metastatic spinal tumors, liver cancer, uterine fibroids, benign prostatic hyperplasia, vertebral compression fractures, and arteriovenous malformations and hemostatic embolization, as well as breast cancer localization and guidance products for the treatment of breast cancer. Further, the company offers non-vascular stents to treat pulmonary and gastrointestinal diseases; dilation balloons to endoscopically dilate strictures; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; and microelectromechanical system sensor components. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.

Receive MMSI News and Ratings via Email

Sign-up to receive the latest news and ratings for MMSI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:MMSI
CUSIP58988910
Phone801-253-1600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$882.75 million
Cash Flow$2.9051 per share
Book Value$17.01 per share

Profitability

Net Income$42.02 million

Miscellaneous

Employees5,783
Market Cap$3.26 billion
Next Earnings Date4/24/2019 (Estimated)
OptionableOptionable

Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) issued its quarterly earnings data on Tuesday, February, 26th. The medical instruments supplier reported $0.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.45 by $0.03. The medical instruments supplier earned $232.25 million during the quarter, compared to the consensus estimate of $231.03 million. Merit Medical Systems had a net margin of 4.76% and a return on equity of 11.26%. The company's revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.33 EPS. View Merit Medical Systems' Earnings History.

When is Merit Medical Systems' next earnings date?

Merit Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, April 24th 2019. View Earnings Estimates for Merit Medical Systems.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems issued an update on its FY19 earnings guidance on Tuesday, February, 26th. The company provided earnings per share guidance of $1.97-2.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.98. The company issued revenue guidance of $1.011-1.03 billion, compared to the consensus revenue estimate of $1.01 billion.Merit Medical Systems also updated its FY 2019 guidance to $1.97-2.08 EPS.

What price target have analysts set for MMSI?

9 brokers have issued twelve-month price targets for Merit Medical Systems' shares. Their predictions range from $58.00 to $79.00. On average, they anticipate Merit Medical Systems' stock price to reach $68.4444 in the next year. This suggests a possible upside of 14.8% from the stock's current price. View Analyst Price Targets for Merit Medical Systems.

What is the consensus analysts' recommendation for Merit Medical Systems?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 sell rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Merit Medical Systems.

What are Wall Street analysts saying about Merit Medical Systems stock?

Here are some recent quotes from research analysts about Merit Medical Systems stock:
  • 1. According to Zacks Investment Research, "Merit Medical exited the fourth quarter of 2018 on a solid note with considerable expansion in adjusted gross margin. A solid guidance of 2019 indicates bright prospects ahead of the stock. Strong growth in the Cardiovascular segment is a positive. Management is optimistic about Merit Medical’s Becton Dickinson deal, the acquisitions of Cianna Medical and Vascular Insights, and the execution of the global growth and profitability plan. New products like EmboCube Embolization Gelatin, the basixTAU Inflation Device, the Prelude Prestige Splittable Sheath Introducer, the Prelude Ideal Sheath Introducer, the PreludeSYNC Radial Hemostasis Device are likely to expand the company’s customer base. However, surging operating expenses is a concern. Headwinds like stiff competition and higher consolidation in the healthcare industry add to the woes. Sluggishness in the Custom kits and procedure trays and Embolization devices units is worrisome." (3/13/2019)
  • 2. Needham & Company LLC analysts commented, "MMSI announced it is has acquired substantially all of the assets of Vascular Insights (private) for $40M of cash upfront and up to $20M in milestone payments. Vascular Insights’ ClariVein products are used to treat superficial venous disease and serve an estimated ~$700M market. MMSI expects the deal to be ~$0.02 dilutive and between $0.00-0.02 accretive to 2018 and 2019 non-GAAP EPS, respectively, and to contribute between $10-11M in revenue in 2019. The Vascular Insights deal is consistent with both our investment thesis and MMSI’s M&A strategy and we reiterate our Buy rating." (12/17/2018)

Has Merit Medical Systems been receiving favorable news coverage?

News headlines about MMSI stock have trended somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Merit Medical Systems earned a coverage optimism score of 1.7 on InfoTrie's scale. They also gave media stories about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term.

Who are some of Merit Medical Systems' key competitors?

What other stocks do shareholders of Merit Medical Systems own?

Who are Merit Medical Systems' key executives?

Merit Medical Systems' management team includes the folowing people:
  • Mr. Fred P. Lampropoulos, Chairman, CEO & Pres (Age 69)
  • Mr. Ronald A. Frost, Chief Operating Officer (Age 57)
  • Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 58)
  • Mr. Joseph C. Wright, Pres of International Division (Age 49)
  • Mr. Raul Parra Jr., CPA, CFO & Treasurer

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.59%), Dimensional Fund Advisors LP (3.68%), Eagle Asset Management Inc. (3.48%), FMR LLC (2.98%), Macquarie Group Ltd. (2.03%) and Perceptive Advisors LLC (1.73%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, Raul Jr Parra, Richard W Edelman and Ronald Frost. View Institutional Ownership Trends for Merit Medical Systems.

Which institutional investors are selling Merit Medical Systems stock?

MMSI stock was sold by a variety of institutional investors in the last quarter, including Partner Fund Management L.P., Eagle Asset Management Inc., Frontier Capital Management Co. LLC, Castleark Management LLC, Dimensional Fund Advisors LP, Timpani Capital Management LLC, Fiera Capital Corp and QS Investors LLC. Company insiders that have sold Merit Medical Systems company stock in the last year include F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Michael E Stillabower, Nolan E Karras, Raul Jr Parra and Ronald Frost. View Insider Buying and Selling for Merit Medical Systems.

Which institutional investors are buying Merit Medical Systems stock?

MMSI stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Norges Bank, Jennison Associates LLC, Pembroke Management LTD, Fisher Asset Management LLC, Amundi Pioneer Asset Management Inc., Geode Capital Management LLC and Geode Capital Management LLC. View Insider Buying and Selling for Merit Medical Systems.

How do I buy shares of Merit Medical Systems?

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $59.64.

How big of a company is Merit Medical Systems?

Merit Medical Systems has a market capitalization of $3.27 billion and generates $882.75 million in revenue each year. The medical instruments supplier earns $42.02 million in net income (profit) each year or $1.69 on an earnings per share basis. Merit Medical Systems employs 5,783 workers across the globe.

What is Merit Medical Systems' official website?

The official website for Merit Medical Systems is http://www.merit.com.

How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]


MarketBeat Community Rating for Merit Medical Systems (NASDAQ MMSI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  247 (Vote Outperform)
Underperform Votes:  220 (Vote Underperform)
Total Votes:  467
MarketBeat's community ratings are surveys of what our community members think about Merit Medical Systems and other stocks. Vote "Outperform" if you believe MMSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Featured Article: What are economic reports?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel